Article Details

New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe ...

Retrieved on: 2022-03-26 20:43:23

Tags for this article:

Click the tags to see associated articles and topics

New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe .... View article details on hiswai:

Excerpt

The platform presentation details new analysis of pooled data from five bimekizumab Phase 3/3b clinical trials, which showed that over 80 percent ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up